» Articles » PMID: 29940987

Reactive Oxygen Species in Haematopoiesis: Leukaemic Cells Take a Walk on the Wild Side

Overview
Publisher Biomed Central
Specialty Oncology
Date 2018 Jun 27
PMID 29940987
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress is related to ageing and degenerative diseases, including cancer. However, a moderate amount of reactive oxygen species (ROS) is required for the regulation of cellular signalling and gene expression. A low level of ROS is important for maintaining quiescence and the differentiation potential of haematopoietic stem cells (HSCs), whereas the level of ROS increases during haematopoietic differentiation; thus, suggesting the importance of redox signalling in haematopoiesis. Here, we will analyse the importance of ROS for haematopoiesis and include evidence showing that cells from leukaemia patients live under oxidative stress. The potential sources of ROS will be described. Finally, the level of oxidative stress in leukaemic cells can also be harnessed for therapeutic purposes. In this regard, the reliance of front-line anti-leukaemia chemotherapeutics on increased levels of ROS for their mechanism of action, as well as the active search for novel compounds that modulate the redox state of leukaemic cells, will be analysed.

Citing Articles

Norchelerythrine from (Thunb.) Pers. promotes differentiation and apoptosis by activating DNA damage response in acute myeloid leukemia.

Lee J, Jeon B, Kwon C, Kim H, Kim T, Seo Y Int J Oncol. 2025; 66(3).

PMID: 39918000 PMC: 11837901. DOI: 10.3892/ijo.2025.5723.


Oxidant/Antioxidant Status in Patients with Negative Myeloproliferative Neoplasms.

Benguella-Benmansour M, Boucherit K, Mesli N Indian J Hematol Blood Transfus. 2025; 41(1):23-30.

PMID: 39917514 PMC: 11794732. DOI: 10.1007/s12288-024-01827-6.


In vitro erythropoiesis: the emerging potential of induced pluripotent stem cells (iPSCs).

Chukwuemeka C, Ndubueze C, Kolawole A, Joseph J, Oladipo I, Ofoezie E Blood Sci. 2024; 7(1):e00215.

PMID: 39726795 PMC: 11671056. DOI: 10.1097/BS9.0000000000000215.


New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies.

Yang Y, Peng H, Wang J, Li F Exp Hematol Oncol. 2024; 13(1):110.

PMID: 39521987 PMC: 11549815. DOI: 10.1186/s40164-024-00573-9.


Deferasirox, an iron chelator, impacts myeloid differentiation by modulating NF-kB activity via mitochondrial ROS.

Jeffries N, Sadreyev D, Trull E, Chetal K, Yvanovich E, Mansour M Br J Haematol. 2024; 205(5):2000-2007.

PMID: 39327763 PMC: 11568922. DOI: 10.1111/bjh.19782.


References
1.
Le S, Hailer M, Buhrow S, Wang Q, Flatten K, Pediaditakis P . Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity. J Biol Chem. 2007; 282(12):8860-72. DOI: 10.1074/jbc.M611777200. View

2.
Megias-Vericat J, Montesinos P, Herrero M, Moscardo F, Boso V, Rojas L . Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy. Pharmacogenomics J. 2017; 18(2):301-307. DOI: 10.1038/tpj.2017.19. View

3.
Mellqvist U, Hansson M, Brune M, Dahlgren C, HERMODSSON S, Hellstrand K . Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood. 2000; 96(5):1961-8. View

4.
Sies H . Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox Biol. 2017; 11:613-619. PMC: 5256672. DOI: 10.1016/j.redox.2016.12.035. View

5.
Suh Y, Arnold R, Lassegue B, Shi J, Xu X, Sorescu D . Cell transformation by the superoxide-generating oxidase Mox1. Nature. 1999; 401(6748):79-82. DOI: 10.1038/43459. View